Ginkgo Bioworks, Inc. 소개
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.
Source: Wikipedia
본사27 DRYDOCK AVENUE, 8TH FLOOR, BOSTON, MA 02210
설립2008
법적 형태C Corporation
상태운영 중
특허특허 289건
INCREASED NITROGEN FIXATION USING BACTERIA WITH IMPROVED AMMONIA SECRETIONUS20260201315A1 · 2026
Scalable, mobile, and reconfigurable modules for processing biological and chemical materialsUS12674810B2 · 2026
주요 수치
법적 정보
| 법인명 | Ginkgo Bioworks, Inc. |
|---|---|
| 법적 형태 | C Corporation |
| SEC CIK | 1648827SEC EDGAR에서 보기 ↗ |
| EIN | 26-3118890 |
| 등기 주소 | 27 DRYDOCK AVENUE, 8TH FLOOR, BOSTON, MA 02210 |
| 상태 | 운영 중 |
출처: SEC EDGAR · 2026년 10월 15일 업데이트
연락처 및 링크
위치
27 DRYDOCK AVENUE, 8TH FLOOR, BOSTON, MA 02210
귀하의 회사인가요?
이 페이지를 무료로 신청하여 로고, 제품, 사진, 채용 공고를 추가하고 리뷰에 답변하세요.
이 페이지 신청